Hong Kong Stocks Begin Week in Red; Xuanzhu Biopharmaceutical Launches Hong Kong IPO

MT Newswires Live
Oct 06

Hong Kong stocks ended lower Monday as the U.S. government shutdown weighed on investor sentiment, prompting a rush to safe-haven assets including gold, while private sector growth in the city softened.

The Hang Seng Index fell by 183.15 points, or 0.67%, to 26,957.77, while the Hang Seng China Enterprises Index decreased 84.96 points, or 0.88%, to 9,573.38.

Hong Kong markets will be closed Tuesday on account of a public holiday.

Hong Kong's private sector activity expanded for a second straight month in September, though growth momentum softened amid a sharper drop in export demand, S&P Global said Monday.

The S&P Global Hong Kong SAR Purchasing Managers' Index fell slightly to 50.4 from 50.7 in August, signaling a modest improvement in overall business conditions.

Meanwhile, the US government shutdown continued, leading to the cancellation of key economic data, including Friday's nonfarm payrolls report.

In corporate news, Xuanzhu Biopharmaceutical (HKG:2575) launched its initial public offering in Hong Kong.

The biopharmaceutical company is offering up to 67,333,500 shares, expected to be priced at HK$11.60 apiece, to raise HK$701 million in net proceeds for the R&D and commercialization of the company's core products

Meanwhile, China Carbon Neutral Development (HKG:1372) posted a loss attributable to owners of HK$7.5 million for the year ended June 30, narrowing significantly from a HK$132.8 million loss for the 18-month period ended June 30, 2024.

Shares of the carbon solutions company were down over 3%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10